Skip to main contentSkip to footer

STERIS Ede The Netherlands Laboratory Receives ISO 17025 Accreditation

September 28, 2026

  • Ensures adherence to international laboratory testing requirements
  • Supports radiation and gas processing locations in The Netherlands

As part of our long-term commitment to supporting global medical device and pharmaceutical manufacturing, STERIS Applied Sterilization Technologies (AST) is pleased to announce that the Ede, The Netherlands laboratory has achieved ISO 17025 accreditation.

ISO 17025 accreditation ensures that the laboratory meets stringent international requirements for competence, impartiality, and consistent operation.
 
This recognition demonstrates that testing methods are globally accepted and confirms STERIS’s adherence to the highest quality and regulatory standards, helping Customers bring products to market with speed and confidence. 

With the addition of the Ede laboratory, STERIS AST continues to expand its network of ISO 17025 accredited laboratories including locations in China, Germany, Malaysia, UK, Italy, Ireland, and the USA, further strengthening our ability to deliver high-quality, compliant laboratory testing services worldwide.
 
To view a copy of our certificate, please go here.

Our team of experienced professionals at the Ede laboratory offers a comprehensive portfolio of laboratory services, including:
  • Bioburden testing
  • Sterility testing
  • Bacterial endotoxin testing
  • Environmental monitoring
  • EO residual testing
  • Irradiation validation 
  • Periodic dose audits (PDAs)
  • Microbial identification
  • Assistance with interpretation of results
  • Guidance on testing methodologies
  • Support for compliance with ISO 11135, ISO 11137, and ISO 17665

Ben Wood, Director of Laboratories and Testing Services – EMEA and APAC at STERIS Applied Sterilization Technologies, comments, “Our Ede laboratory continues to reach new milestones, and achieving ISO 17025 accreditation is a proud moment for the team. It reflects recent investments in our capabilities and reinforces our commitment to quality, while highlighting the importance of providing Customers in the Netherlands with comprehensive laboratory testing services.”

In addition to the Ede, The Netherlands laboratory, STERIS supports medical device and pharmaceutical manufacturing throughout Europe with a technology-neutral offering that includes electron beam, ethylene oxide, gamma, and X-ray processing, enabling Customers to benefit from a fully integrated offering that supports product safety, regulatory compliance, and speed to market.

Learn more about this location here. 

This milestone reflects STERIS’s continued investment in quality, innovation, and Customer support across our global network.

STERIS Ede, The Netherlands Laboratory

About STERIS

STERIS is a leading global provider of products and services that support patient care with an emphasis on infection prevention. 

WE HELP OUR CUSTOMERS CREATE A HEALTHIER AND SAFER WORLD by providing innovative healthcare and life sciences products and services. 

For more information, visit www.steris.com.

 
Related Posts
STERIS Venlo, NL Facility
October 8, 2026
As part of our long-term commitment to supporting global medical device manufacturing, STERIS is pleased to announce the completion of the expansion of its existing Venlo, The Netherlands ethylene oxide and X-ray processing facility to include a second X-ray processing line. 
STERIS Alajuela, Costa Rica
September 29, 2026

As part of our long-term commitment to supporting global medical device and pharmaceutical manufacturing, STERIS is pleased to announce the expansion of the laboratory testing capabilities available at our facility in Alajuela, Costa Rica.

Montreal Opening Announcement
August 24, 2026

As part of our commitment to ensuring patient and consumer safety, STERIS is pleased to announce the competition of a new electron beam (E-beam) processing facility in Montreal, Canada.